Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience

Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience

Bibliographic Details
Main Authors: Ulrike Heinicke, Elisabeth Adam, Michael Sonntagbauer, Andreas von Knethen, Kai Zacharowski, Holger Neb
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Critical Care
Online Access:http://link.springer.com/article/10.1186/s13054-020-03143-7

Internet

http://link.springer.com/article/10.1186/s13054-020-03143-7

Similar Items